Zai Lab and Amgen Collaborate on Lung Cancer Clinical Trial for Zoci and Imedlidtra Combination Therapy

Zai Lab and Amgen are partnering on a clinical trial to evaluate Zai Lab's lung cancer therapy, zoci, in combination with Amgen's Imdelltra. The phase 1b study will assess the safety and efficacy of the combination treatment for extensive-stage small cell lung cancer. This collaboration aims to bring a new potential treatment option to patients with this aggressive form of lung cancer.